Delivery Order SPE2DB20D2014-SPE2DB25FB67P
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,431.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,844,144 units of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes treatment medication. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price, non-set-aside contract. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This federal contract award, valued at $1,197.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (SPE2DB25D3017|SPE2DB25FVHTB) for the supply of Lantus Solostar 100 unit/ml 3ml, a diabetes medication. The contract has an ultimate completion date of April 16, 2025 and is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The contract has an ultimate completion date of March 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,734.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of February 9, 2024, is for the delivery of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $2,592.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,997,716 units of Lantus Solostar 100 unit/mL 3mL, a prescription medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant...
This federal contract award, valued at $7,411.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. It is a firm-fixed-price delivery order with an ultimate completion date of April 11, 2025. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,406.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for DLA Troop Support Medical to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,988.47 fixed-price contract is for the supply of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The award has an ultimate completion date of August 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,022.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Lantus Solostar 100 unit/ml 3ml, a diabetes medication. This is a firm fixed-price delivery order contract with a completion date of May 15, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,098.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a diabetes medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This IDC enables Amerisourcebergen to supply a wide range of...